The results obtained with an enzyme-linked immunosorbent assay (ELISA) for detection of human herpesvirus 6 (HHV-6) immunoglobulin G using a single 1:100 dilution of serum correlated well with those found by an indirect fluorescence microscopic assay (IFA) (r ‫؍‬ 0.71). Concordant results were found in all 7 paired serum samples obtained from patients with acute primary infections and in 37 of 41 (90.24%) single serum samples. Fourteen serum samples (25%) which yielded nonspecific results by IFA were evaluable by ELISA. In a serologic survey using the ELISA, a disproportionate number of 12-month-old infants had low differenceof-optical-density values, suggesting that maternal antibody might persist beyond a year of age. This finding and the rises in antibody to HHV-6 found in patients with primary cytomegalovirus infections might lead to overestimation of HHV-6 infection rates in young children in seroprevalence studies. Other herpesvirus infections produced lesser effects on anti-HHV-6.
Human herpesvirus 6 (HHV-6) was first isolated in 1986 from peripheral-blood leukocytes of patients with lymphoproliferative disorders (25) , and in 1988 it was identified as the causative agent of roseola (31) . Subsequent studies have shown that HHV-6 infection is a significant cause of acute febrile illnesses with or without rash in infants and children (2-4, 17, 18) . After the first year of life, the likelihood that HHV-6 would result in a febrile convulsion increased to approximately one in three (17) .
In order to elucidate the etiologic role of HHV-6 in other illnesses with which it now has been temporally associated (2, 9, 13, 14, 24, 29, 30) , it is essential to be able to interpret the results of serologic testing. Using an enzyme-linked immunosorbent assay (ELISA) which tests a single 1:100 dilution of serum, we were able to demonstrate that cross-reacting herpes antigens and passively acquired antibody may influence the interpretation of serologic measurement of anti-HHV-6. The results of the ELISA were compared with those obtained with an indirect fluorescence microscopic assay (IFA).
MATERIALS AND METHODS
Serum samples. Seven pairs of serum samples from patients with acute HHV-6 infection and 55 single serum samples obtained from children under the age of 3 years who presented to the emergency room for various problems at Strong Memorial Hospital in Rochester, N.Y., were tested for HHV-6 antibody by ELISA. They had been tested previously by IFA (17) .
Serum samples obtained from 290 healthy children 1 to 17 years old, which had been collected in 1984 to 1986 and 1988 to 1989 during vaccine trials, were tested by ELISA for anti-HHV-6. Five of these serum samples which were found to have the lowest positive values were tested for antibodies to cytomegalovirus (CMV), herpes simplex virus type 1 (HSV-1), and varicella-zoster virus (VZV) in order to determine whether the reactivity to HHV-6 might have been due to heterologous reactions resulting from infections with these viruses. In addition, six pairs of serum samples from individuals who had seroconverted to CMV, four from individuals who had seroconverted to HSV-1, and five from individuals who had seroconverted to VZV were tested for anti-HHV-6. These pairs of serum samples were obtained from individuals enrolled in long-term studies during which serum specimens were collected at intervals, and the five serum samples from healthy children were obtained before and after administration of live varicella vaccine. To determine whether individuals infected with HHV-6 might have increases in other herpes antibodies, seven pairs of serum samples from individuals who had seroconverted to HHV-6 also were tested with antigens to VZV, HSV-1, or CMV.
Preparation of antigens for HHV-6 ELISA. Cord blood obtained from normal uncomplicated deliveries was collected in tubes containing the anticoagulant EDTA and was processed within 24 h of collection. Cord blood mononuclear cells (CBMNC) were separated by Ficoll-Hypaque density gradient, centrifuged twice, washed with phosphate-buffered saline, and incubated at 37°C for 48 to 72 h in stimulation medium. This medium consisted of RPMI 1640 containing 20% fetal calf serum, penicillin, streptomycin, amphotericin B, 5 g of phytohemagglutinin (Sigma, St. Louis, Mo.)/ml, and 0.05 g of hydrocortisone (Sigma)/ml. Cultures of 2 ϫ 10 6 cells/ml in the maintenance medium, consisting of RPMI 1640 containing 20% fetal calf serum, the antibiotics listed above, 5% interleukin 2 (Advanced Biotechnologies, Inc., Columbia, Md.), and 2.5 g of phytohemagglutinin/ml were inoculated with cell-free HHV-6 which had been isolated from a patient with roseola (courtesy of Yoshizo Asano, Tkyoake, Japan). The cultures, which were incubated at 37°C, were replenished with fresh medium every 2 to 3 days. Cytopathic change, consisting of large ballooning cells, started on day 5 and peaked on day 7. At this time the infected cells were washed, harvested, and disrupted by treatment with a Sonifier 450 (Branson) using a constant cycle for 30 s (output, 25 to 30). Uninfected CBMNC were processed in an identical manner to provide a control.
Wells of Nunc 96-well Maxisorb microtiter plates (Interlab, Thousand Oaks, Calif.) were coated with HHV-6 antigen or control in 0.06 M carbonate buffer (pH 9.6) and incubated at 4°C in a humidified environment for at least 72 h before use. The coated plates could be used for up to 3 months. The ELISA method used in our laboratory (8, 21) , including the assays for CMV and HSV-1 (16) and for VZV (28), has been described in detail elsewhere. The results were expressed as difference of optical density (DOD), which was calculated by subtracting the average optical density of two controls from the average of two antigen values multiplied by a thousand. Each lot of antigen was standardized by block titration, by testing multiple concentrations of antigen with alkaline phosphatase-conjugated anti-human antibody (goat antibody to human immunoglobulin G [IgG] ␥ chain; Tago Immunologicals). The minimal concentration that yielded the highest DOD with the least background was chosen to be used in the antibody assays.
Establishment of the seronegative range. The method for determining the seronegative range has been described elsewhere (16) . Twenty cord serum samples were treated with protein G (Quik-Sep IgM assay; Isolab, Inc., Akron, Ohio) twice to remove IgG. The treated serum samples were tested, and the mean DOD plus 4 standard deviations was used to calculate the highest value defined as seronegative. All the 20 treated serum samples had DODs below 37, which was determined to be the highest seronegative value.
IFA method, viral culture, and PCR. IFA, viral culture, and PCR were performed at the Rochester Medical Center. Details of the methods were described previously (17) . A value of Ͻ1:10 for IFA was defined as seronegative.
RESULTS
Comparison of ELISA and IFA for detection of HHV-6 antibody. Of the single serum samples obtained from 55 different patients who visited the emergency room with various illnesses, 14 (25%) were not evaluable by IFA because of nonspecific reactivity. When these samples were tested by ELISA, 11 were positive and 3 were negative. Of the 41 samples which could be compared, 8 were negative and 29 were positive by both methods. There were four discrepancies. Three specimens were positive by ELISA but negative by IFA, and one was positive by IFA but negative by ELISA. There was a good correlation (r ϭ 0.71) between the ELISA DODs and IFA titers (Fig. 1) .
Seven patients with acute HHV-6 infection whose peripheral-blood mononuclear cells were positive by PCR and culture for HHV-6 were shown to have seroconverted both by IFA and by ELISA. A striking increase in the ELISA DOD, far above the highest seronegative value, 37, was noted in each of the serum samples obtained during convalescence (Table 1) .
Seroprevalence study by ELISA. Of the 290 specimens tested, 76.9% (60 of 78) of specimens from the 12-to 24-month age group, 92.3% (72 of 78) from the 25-to 36-month age group, 96.3% (52 of 54) from the 37-to 60-month age group, and 97.5% (78 of 80) from those older than 60 months were positive. The highest individual ELISA DODs generally were found in the youngest age group; thereafter, levels tended to decline with increasing age (r ϭ Ϫ0.311; P Ͻ 0.001). In the seropositive group, 11 of 24 (45.8%) of those tested around the time of their first birthday had positive DODs below 200, while only 9 of the remaining 238 older children (3.7%) had similar low DODs (P Ͻ 0.001 by the Fisher exact test) (Fig. 2) .
Heterologous reactions between herpesviruses. Serum samples were tested for heterologous reactions, both for the effect of HHV-6 infection on other herpes antibodies and for the effect on anti-HHV-6 of infection with other herpesviruses. Of the six CMV seroconverters who were tested for HHV-6, two remained seronegative and two seroconverted, while two who were initially seropositive showed a notable rise in convalescent-phase ELISA DOD (from 135 to 448 and from 80 to 208). All four HSV-1 seroconverters and all five VZV seroconverters were initially seropositive for HHV-6. All, except for one of the VZV seroconverters, had slight increases in convalescentphase anti-HHV-6 ELISA DOD, but none approached the increases in anti-HHV-6 in the CMV seroconverters (Tables 2  through 4) .
Five seropositive serum samples from the survey with very low DODs, i.e., 68 or below, were tested to determine whether these might have represented a cross-reacting antibody which resulted from acute infection with another herpesvirus; all were negative for CMV antibody, one had a low positive value for HSV-1, and one had a low positive value for VZV.
Seven individuals who were found to have seroconverted to HHV-6 were tested against CMV, HSV-1, and VZV. None of those who were initially seronegative to those herpesviruses seroconverted. One of those initially seropositive for CMV (Table 5 , patient 3) and one individual seropositive for HSV-1 (patient 4) had notable increases (from 755 to 1156 and from 116 to 416) in their convalescent-phase DODs, while the rest had only marginal increases or decreases (Table 5) .
DISCUSSION
The seroprevalence data obtained by using the ELISA were similar to those found previously by the IFA method (7, 22, 32) . More than 75% of individuals were found to be seropositive within the first 2 years of life, and 92% were found to be seropositive within the first 3 years. However, the number of immune subjects may be overestimated in all of the studies for two reasons. A disproportionate number of seropositive 12-month-old babies with low levels of antibody was found in the current study, suggesting that these may represent babies with passively acquired maternal antibody rather than babies who had been infected with HHV-6.
CMV infections occur commonly during the 2nd year of life (23), and, as described previously (1, 19) , some individuals who had CMV seroconversions were found to have significant increases in anti-HHV-6 (10); two seroconverted (Table 2) . Thus, some of the findings of HHV-6 seropositivity may have resulted from a cross-reactive antibody in individuals who were infected with CMV rather than from infection with HHV-6. As there is 39% homology between glycoprotein B sequences of these viruses (11), this is not surprising. Four of the six individuals with primary CMV infection had simultaneous rises in anti-HHV-6; it is unlikely that this was due to the two infections occurring coincidentally.
We found some increases in anti-CMV in HHV-6-infected individuals, but these were not of the same magnitude as the increases of anti-HHV-6 in primary CMV infections. The asymmetry of the response is more consistent with the heterologous response reported with other herpesviruses (26) than with coincidental infections. Others have not found rises in anti-CMV (1) or antibody against other herpesviruses (5, 19) in primary HHV-6 infections; the data for HHV-7 are conflicting (6, 12, 15, 31) .
The single-dilution assay used in the present study requires smaller blood volumes than the IFA. It can be performed with 0.005 ml of blood, which can be easily obtained from a finger prick. It is technically easier to perform than the IFA and can assay specimens which could not be tested with the IFA because of nonspecific reactivity. Thus, this ELISA is ideally suited for both diagnosis and serologic surveys. b Seronegativity was defined as a DOD of Յ37 for HHV-6, Յ79 for CMV, Յ55 for HSV-1, and Յ65 for VZV. Neg, seronegative.
